<unk> (Injection solution in 5% dextrose) is an antianginal that is FDA approved for the treatment of peri-operative hypertension; for control of congestive heart failure in the setting of acute myocardial infarction; for treatment of angina pectoris in patients who have not responded to sublingual<unk> and β-blockers; and for induction of intraoperative hypotension.   Common adverse reactions include headache, lightheadedness and hypotension.
Nitroglycerin 
Nitroprusside
Endralazine
Imolamine
Amrinone
Papaverine
Adenosine
Nadolol 